PRESS RELEASE
News
-
-
-
-
-
PRESS RELEASE
Oxurion Receives Transparency Notifications from UBS Group AG
Oxurion NV received transparency notifications from UBS Group AG regarding share holdings, in compliance with Belgian Transparency legislation. The company is a biopharmaceutical group focusing on therapeutic innovation and clinical research technologies -
-
PRESS RELEASE
Oxurion Receives Transparency Notifications from Atlas Special Opportunities II LLC
Oxurion NV receives transparency notifications regarding changes in shareholding from Atlas Special Opportunities II, LLC as per Belgian Transparency legislation. Company combines therapeutic innovation with technology for new treatments -
-
PRESS RELEASE
Oxurion announces it obtained an improved indicative EUR 30 million financing offer to initiate its plan to diversify by allocating part of its treasury into digital assets
Oxurion NV receives €30 million financing offer from Atlas Special Opportunities for investment in digital assets. Company remains confident in closing the transaction by August 2025 -
